*Refresh the page if the below document does not appear.
Govt's expert panel to meet pharma industry on Friday to solve Unethical Marketing Practices issue
A top level panel of experts nominated by the Modi Government are going to meet the pharma company officials to discuss solutions to stop unethical marketing practices related to the industry.
US FDA gives final approval to Mesalamine extended-release capsules
Alembic Pharma reported that the US FDA has given a final approval to their ANDA (Abbreviated New Drug Application) for Mesalamine ExtendedRelease Capsules USP 0.375g. It is used for the maintenance of remission of ulcerative colitis in adults.
Persistent inflation and pricing pressures impact pharma industry: ICRA
ICRA (Investment Information and Credit Rating Agency) took a sample set of revenue growth of 16 Indian pharma companies and they showed a revenue growth of 4.9 per cent YoY in Q1 Financial Year 2023.
AstraZeneca's omnichannel activities scaled up by Indegene
Indegene, a digital-first life sciences commercialization firm, is assisting biopharmaceutical major AstraZeneca in scaling up its omnichannel operations around the globe in order to provide a more personalised client experience.
GSK profits rise on consumer health spinoff
On Wednesday, the british drugmaker announced that their third-quarter net profit rocketed almost ten times to £10.3 billion ($11.5 billion) due to the spectacular spinoff of consumer healthcare unit Haleon.
Glenmark Pharma gets US FDA approval for generic medication
The company declared that it has received a nod to manufacture and market Sodium Phenylbutyrate tablets in America. The drug is indicated for the treatment of urea cycle disorders.
Metaverse gaining traction in global pharma industry
Metaverse’s impact on the life sciences
business is not fully known. However, by
merging AI, VR, and AR, the metaverse can
play a significant role in altering the drug
development process, and pharma firms can
benefit from faster time to market, improved
learning, and development experience.